NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, April 15, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“Canada House” or the “Company”) is pleased to announce the appointment to its Board of Directors of Gaetan Lussier and Shawn Graham.
Mr. Lussier was a deputy-minister for 18 years of which 12 years were in Ottawa with Agriculture-Canada and Employment and Immigration. He was also President of Weston Bakery (Quebec) and CEO of Culinar, both food companies. Mr. Lussier has extensive Board experience having sat as a Director on various boards including Shoppers Drug Mart. Presently, Mr. Lussier is Chairman of the board of 3 Sixty Secure Corp., a logistics and security company dealing primarily in the field of cannabis. Mr Lussier received the Order of Canada in 1981 and brings various expertise to the Board of Canada House. Mr Lussier holds a B.S.A, M Sc, PhD and O. C.
Mr. Graham served as the 31st Premier of the Province of New Brunswick, Chair of the Council of The Federation, Co-chair of the Northeastern Governors and Eastern Canadian Premiers, and Co-chair of a Pan-Canadian Trade Mission to China. Currently, Mr. Graham is President and CEO of G&R Holdings Inc., a company that assists in the development and implementation of international projects and business alliance strategies, with a special focus on globalizing with China.
Mr. Graham was awarded an Honorary Doctor of Laws Degree from the University of New Brunswick and was named Visionary of the Year Award by the Global Intelligent Community Forum in New York City, NY. At present he is a national director for Ducks Unlimited (Canada) —North America’s leading wetlands conservation organization and serves as an advisor to the University of New Brunswick’s Faculty of Business Administration.
Concurrent with the appointment of Mr. Lussier and Mr. Graham, Mr. Mike Southwell tendered his resignation as a Director of the Company. Mr. Southwell will continue to be involved with the Company in the capacity of strategic advisor.
“On behalf of the Board of Directors, I would like to thank Mike for his commitment to the Company over many years and look forward to continuing to benefit from his extensive industry knowledge and unique experience. At the same time we are thrilled to welcome Gaetan and Shawn to the Board. They bring tremendous experience and strong skill sets to the Board which we anticipate will contribute further the Company’s maturation and growth,” commented Dennis Moir, Chair of the Board of Directors.
In connection with the appointment of Mr. Lussier and Mr. Graham, an aggregate of 1,000,000 stock options were issued at an exercise price of $0.15, expiring on April 15, 2024.
Canada House Wellness Group Inc.
Canada House is the parent company of Abba Medix Corp, Canada House Clinics Inc. and Knalysis Technologies. The Company's mission is to become the leading cultivator of premium craft cannabis and provider of cannabinoid therapy, targeting the medical cannabis markets globally For more information please visit http://www.canadahouse.ca or www.sedar.com.
For further information, please contact:
Boom Capital Markets
Steve Low
647-620-5101
steve@boomcapitalmarkets.com
Canada House Wellness Group Inc.
Chris Churchill-Smith
CEO
514-313-0102
chris.smith@canadahouse.ca
Cautionary Statement Regarding Forward Looking Information. This press release contains forward-looking statements, including statements that relate to, among other things, the Company’s clinic, production and technology businesses, its future plans, the Company’s markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, “possible”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective” and “continue” (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, among other things, the regulations related to cannabis use under the Access to Cannabis for Medical Purposes Regulations and the act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts, passed by the Canadian Federal government, making cannabis legal for recreational use by October 17, 2018; Company liquidity and capital resources, including the availability of additional capital resources to fund its activities; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; and the ability to execute strategic plans. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company’s most recent annual and interim Management’s Discussion and Analysis under “Risk and Uncertainties” as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.